Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin in Acute Ischemic Stroke
NCT06858436Phase 4Not yet recruiting
- Sponsor
- Taichung Veterans General Hospital
- Start
- Apr 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of canagliflozin in ischemic stroke (2 arms), sponsored by Taichung Veterans General Hospital. Primary endpoints: Occurrence of malignant edema, Modified Rankin Scale at 3 months and 1 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
canagliflozin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06858436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06858436.